Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists

https://doi.org/10.1016/j.bmcl.2005.06.099Get rights and content

Abstract

Structure–activity relationship studies leading to the discovery of novel mGlu5 receptor antagonists are described. These compounds show high in vitro potency, have good in vivo receptor occupancy, and a reasonable intravenous pharmacokinetic profile.

Section snippets

Acknowledgments

The authors thank Bill Bray and Joyce James for expert technical assistance.

References and notes (27)

  • S. Ozawa et al.

    Prog. Neurobiol. (Oxford)

    (1998)
  • J. Brodkin et al.

    Pharmacol. Biochem. Behav.

    (2002)
  • W.P.J.M. Spooren et al.

    Eur. J. Pharmacol.

    (2002)
  • B. Schulz et al.

    Neuropharmacology

    (2001)
  • F. Gasparini et al.

    Neuropharmacology

    (1999)
  • N.D.P. Cosford et al.

    Bioorg. Med. Chem. Lett.

    (2003)
  • N.D. Smith et al.

    Bioorg. Med. Chem. Lett.

    (2004)
  • J.R. Roppe et al.

    Bioorg. Med. Chem. Lett.

    (2004)
  • M.A. Varney et al.

    J. Pharmacol. Exp. Ther.

    (1999)
  • L.P. Daggett et al.

    Neuropharmacology

    (1995)
  • Schweiger, E. J.; Tehrani, L.; King, C. D.; Green, M. D. Unpublished...
  • See Ref. 17, supporting...
  • H. Brauener-Osborne et al.

    J. Med. Chem.

    (2000)
  • Cited by (15)

    View all citing articles on Scopus
    View full text